Taipei Exchange - Delayed Quote TWD

DV Biomed Co., Ltd. (6539.TWO)

44.20 -0.60 (-1.34%)
At close: 2:33 PM GMT+8
Loading Chart for 6539.TWO
DELL
  • Previous Close 44.80
  • Open 44.55
  • Bid 43.35 x --
  • Ask 44.20 x --
  • Day's Range 43.35 - 44.70
  • 52 Week Range 42.60 - 205.73
  • Volume 43,881
  • Avg. Volume 15,200
  • Market Cap (intraday) 905.234M
  • Beta (5Y Monthly) 0.26
  • PE Ratio (TTM) 6.04
  • EPS (TTM) 7.32
  • Earnings Date --
  • Forward Dividend & Yield 6.80 (15.17%)
  • Ex-Dividend Date May 9, 2024
  • 1y Target Est --

DV Biomed Co., Ltd. manufactures and sells medical-grade skin care products in Taiwan and internationally. The company provides health and slimming services; and acts as an agent of medical beauty fillers and medical beauty equipment. It also offers health food, including light and energy drinks; face care; and beauty products and services. The company was founded in 2011 and is based in Taipei, Taiwan.

www.dvbiomed.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 6539.TWO

Performance Overview: 6539.TWO

Trailing total returns as of 5/28/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

6539.TWO
68.02%
TSEC weighted index
21.90%

1-Year Return

6539.TWO
74.46%
TSEC weighted index
32.43%

3-Year Return

6539.TWO
70.02%
TSEC weighted index
31.66%

5-Year Return

6539.TWO
51.10%
TSEC weighted index
111.52%

Compare To: 6539.TWO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6539.TWO

Valuation Measures

Annual
As of 5/27/2024
  • Market Cap

    905.24M

  • Enterprise Value

    1.02B

  • Trailing P/E

    6.04

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.60

  • Price/Book (mrq)

    0.86

  • Enterprise Value/Revenue

    0.66

  • Enterprise Value/EBITDA

    2.61

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.59%

  • Return on Assets (ttm)

    5.61%

  • Return on Equity (ttm)

    13.96%

  • Revenue (ttm)

    1.54B

  • Net Income Avi to Common (ttm)

    153.03M

  • Diluted EPS (ttm)

    7.32

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    276.59M

  • Total Debt/Equity (mrq)

    37.04%

  • Levered Free Cash Flow (ttm)

    -883.12k

Research Analysis: 6539.TWO

Company Insights: 6539.TWO

Research Reports: 6539.TWO

People Also Watch